These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23054691)

  • 21. [Hereditary angioedema. Family history and clinical manifestations in 58 patients].
    Romero DS; Di Marco P; Malbrán A
    Medicina (B Aires); 2009; 69(6):601-6. PubMed ID: 20053597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema.
    Satomura A; Fujita T; Nakayama T
    Intern Med; 2018 Mar; 57(5):751-755. PubMed ID: 29093422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.
    Rubinstein E; Stolz LE; Sheffer AL; Stevens C; Bousvaros A
    BMC Gastroenterol; 2014 Apr; 14():71. PubMed ID: 24712435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review.
    Kemp JG; Craig TJ
    Allergy Asthma Proc; 2009; 30(5):493-9. PubMed ID: 19843403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hereditary angioedema. Treatment of acute attacks in Argentina].
    Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
    Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A; Mansi M; Azin GM; Wu MA; Periti G; Casazza G; Vacchini R; Suffritti C; Cicardi M
    Allergy; 2015 Dec; 70(12):1553-8. PubMed ID: 26304015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies.
    Wahn V; Aberer W; Eberl W; Faßhauer M; Kühne T; Kurnik K; Magerl M; Meyer-Olson D; Martinez-Saguer I; Späth P; Staubach-Renz P; Kreuz W
    Eur J Pediatr; 2012 Sep; 171(9):1339-48. PubMed ID: 22543566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
    Bork K; Craig TJ; Bernstein JA; Feuersenger H; Machnig T; Staubach P
    Allergy Asthma Proc; 2015; 36(3):218-24. PubMed ID: 25803207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
    Bernstein JA; Relan A; Harper JR; Riedl M
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
    Bernstein JA; Ritchie B; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz DS; Obtulowicz K; Reshef A; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Schindel F; Craig TJ
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):149-54. PubMed ID: 20674826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
    Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
    Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
    Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
    J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
    Moellman JJ; Bernstein JA
    J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
    Baker JW; Craig TJ; Riedl MA; Banerji A; Fitts D; Kalfus IN; Uknis ME
    Allergy Asthma Proc; 2013; 34(2):162-9. PubMed ID: 23484892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.
    Aberer W; Maurer M; Reshef A; Longhurst H; Kivity S; Bygum A; Caballero T; Bloom B; Nair N; Malbrán A
    Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.